Fact CheckerSign in

NCT07445412Recruiting

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy - IGROWtoh

Source: ClinicalTrials.gov · Last updated 3 Mar 2026

Brief summary (registry, in English)

The goal of this national mutlticenter observational study is to learn and describe trends over time in the use of techniques for inducing hepatic hypertrophy in Italy. Patients will be treated according to the current clinical practice of the participating centers and will be observed from the moment of recruitment and throughout their stay. Information on vital status will be collected, as far as possible, for up to 5 years after surgery in order to record any events that occur in a timely manner. There are also plans to retrospectively collect data on patients who underwent hypertrophic techniques in the previous 10 years, in order to establish a historical cohort for each center that can be used for comparison with the prospective cohort.

Status (registry)
Recruiting
Study type
Observational
Enrollment
2000 (estimated)
First submitted
17 Feb 2026
Start date
22 Oct 2024
Primary completion date
Oct 2039
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT number
NCT07445412

What you commit to

  • Study type: Observational
  • Planned participants: 2000
  • From 22 Oct 2024 to the primary completion date, Oct 2039
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • pregnant or breastfeeding woman

Who the study is looking for

  • Patients aged 18 or older
  • Obtaining informed consent
  • Patients with liver neoplasia (benign or malignant) and with a future liver remnant volume deemed insufficient (\<20%-40%) by the local multidisciplinary team

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Irccs Azienda Ospedaliero - Universitario Di Bologna
Coordinator of this site? Confirm its status
BolognaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.